Core Viewpoint - The deadline for the award application for the Global MedTech Innovation Awards has been extended to June 20, 2025, to allow more time for participants to prepare and submit their materials, aiming to showcase innovations and contributions in the medical device field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of approximately 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference will feature a main stage for showcasing and awarding global medical technology innovations [5]. Group 2: Award Categories - The awards to be presented include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application and Evaluation Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, 2025, with results to be announced between June 30 and July 4, 2025 [11]. - The awards will be presented on July 17, 2025, after the confirmation of trophy production [11]. Group 4: Target Audience and Standards - The awards target various entities including medical device and digital health technology companies, clinical doctors, researchers, and key suppliers, with specific standards for originality, advancement, and potential for industrialization [7][10].

Core Viewpoint - The deadline for the award application for the Global MedTech Innovation Awards has been extended to June 20, 2025, to allow more time for participants to prepare and submit their materials, aiming to showcase innovations and contributions in the medical technology field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of approximately 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference will feature a main stage for showcasing and awarding global medical technology innovations [5]. Group 2: Award Categories - The awards to be presented include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application and Evaluation Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, with results to be announced between June 30 and July 4, and the awards to be presented on July 17, 2025 [11]. - Participants must meet specific criteria based on their roles, such as medical device companies, clinical doctors, researchers, and service providers, ensuring that the innovations are original, advanced, and have potential for large-scale industrialization [7][10].

Core Viewpoint - The article announces the extension of the application deadline for the Global MedTech Innovation Awards to June 20, 2025, to allow more time for participants to prepare their submissions and showcase their innovations in the medical technology field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of around 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference aims to highlight and award groundbreaking achievements in medical technology, with a focus on innovation, application, and service contributions [4][8]. Group 2: Award Categories - The awards include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, with results to be announced between June 30 and July 4 [11]. - Participants must submit specific documents including a personal resume, a summary of research achievements, and any relevant supporting materials [13].

原标题：深圳技术大学成立医工交叉创新研究院 近日，深圳技术大学成立医工交叉创新研究院。该研究院将以解决产业"卡脖子"技术为核心目标，聚焦 高端医疗装备、智能助力助老助残装备、医疗大数据与医疗信息系统、跨尺度诊疗装备与系统四大发展 方向，培养医工交叉复合型人才，打造产学研用一体化创新平台，为医疗器械产业及医疗卫生事业赋 能，服务地方经济和民生福祉。 深圳技术大学副校长梁永生介绍，学校依托深圳坪山区生物医药产业优势，成立医工交叉创新研究院， 既是贯彻落实国家科技创新战略的具体行动，也是服务地方经济和医疗事业高质量发展的重要举措。 据了解，该研究院是深圳技术大学首个"弹性配置"的研究院，整合了深圳技术大学大健康与环境工程学 院、中德智能制造学院、大数据与互联网学院、城市交通与物流学院等多个学科资源。中国工程院外籍 院士余艾冰、加拿大工程院院士孟庆虎等10位院士和行业领军人才领衔的战略咨询团队，以及解放军总 医院创伤骨科主任张立海等15位临床医学和人工智能等领域权威专家组建的科技专家委员会，为研究院 发展提供指导和支持。 医工交叉创新研究院执行院长匡绍龙表示："我们将积极推进各类科学技术研究，如手术机器人、脑机 接口 ...

Core Insights - The article highlights the achievement of Qiu Yueqi, a doctoral student from Shanghai Jiao Tong University, who won the ISMRM Young Investigator Award at the 2025 International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting in Hawaii, making her the sole recipient of this prestigious award this year [1][3][7]. Group 1: Award and Recognition - Qiu Yueqi's research team, led by Professor Zhang Zhiyong, won the Prince-Meaney Translational Science Award for their paper titled "Spatiotemporal Encoding MRI in a Portable Low Field System," which is one of the three major awards given by ISMRM [3][10]. - The Prince-Meaney Translational Science Award is recognized as the highest honor in the field of translational research in magnetic resonance, awarded annually to groundbreaking research with significant clinical application value [3][7]. Group 2: Research Contributions - The awarded research innovatively developed a SPEN (spatiotemporal encoding) acquisition method suitable for portable low-field devices, which shows less geometric distortion in under-sampled images compared to traditional EPI (echo-planar imaging) techniques [10]. - The research team has demonstrated a series of innovations in SPEN technology, including SPEN DTI, SPEN RF-encoded, and xSPEN, which provide critical technical support for the clinical application of portable MRI devices [10][15]. Group 3: Institutional Impact - This award marks the first time that Shanghai Jiao Tong University and China have received the Prince-Meaney Translational Science Award, showcasing the university's leading research capabilities in the interdisciplinary field of medical engineering [7]. - The achievement reflects significant progress in China's core technology development for medical devices, paving new pathways for the widespread application of magnetic resonance technology [7]. Group 4: Future Directions - Qiu Yueqi's research team is exploring further possibilities in low-field magnetic resonance, collaborating with the Children's Medical Center of Shanghai Jiao Tong University to apply portable low-field MRI systems and new imaging technologies in pediatric brain development research [15]. - The team aims to integrate SPEN technology with artificial intelligence and precision medicine to enhance the diagnostic efficacy of portable MRI, opening new avenues for early intervention and personalized treatment of major diseases [15].

Core Insights - The "Artificial Bladder" project won the first Doctoral Postdoctoral "Hero Cup" Innovation and Entrepreneurship Competition in Wuhan, securing a record investment of 15 million yuan from venture capital institutions [1][9] - The project is currently conducting clinical research related to Class II medical devices, with clinical trials expected to commence within the year [1] - The project integrates magnetic control technology, soft robotics, and medical polymer materials, aiming to provide a cost-effective solution for bladder treatment [4][10] Group 1: Project Development - The "Artificial Bladder" is the only product in the industry that has completed large animal validation, with a projected price reduction of two-thirds compared to existing mainstream treatment options [1][10] - The project is a collaboration between the postdoctoral workstation at Tongji Hospital and the School of Integrated Circuit at Huazhong University of Science and Technology, highlighting the importance of interdisciplinary cooperation [4][5] - The system allows real-time monitoring of bladder capacity and pressure through a mobile application, enhancing user experience [4] Group 2: Investment and Market Potential - The project aims to capture 30% of the domestic market share within three years, targeting the 30 million neurogenic bladder patients globally, with a significant portion in China [10][11] - The global bladder treatment market is valued at 45.2 billion yuan, with the product priced at 50,000 yuan, significantly lower than imported alternatives [8][10] - The project has received a total of 15 million yuan in angel investment, marking the highest single investment in this competition [9] Group 3: Ecosystem and Support - The "Hero Cup" competition has established a comprehensive ecosystem that supports teams from pre-competition training to post-competition incubation [8] - The project benefits from strong policy support, a robust biomedicine industry, and a pool of top-tier talent in Wuhan [10] - The team has filed six invention patents, two utility model patents, and two software copyrights related to the project, indicating a strong focus on innovation [11]

Core Viewpoint - The medical technology industry is at a crossroads of breakthrough and reconstruction, with advancements in AI-assisted diagnosis, high-end intelligent diagnostic equipment, innovative medical materials, and regenerative medicine reshaping disease discovery, treatment, and management [1] Group 1: Conference Overview - The Second Global MedTech Conference will be held on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, aiming to promote the collaborative development of the global medical technology industry chain, innovation chain, and clinical application [1][4] - The first conference, Global MedTech Conference 2024, was organized by Siyu [2] Group 2: Awards and Recognition - The conference will present several awards to recognize breakthroughs in medical technology, including the 2025 Global MedTech Innovation Award and the 2025 Global MedTech Innovation Application Award [3][7] - The awards aim to honor cutting-edge technological advancements, successful results transformation, and outstanding services in the medical technology field [3] Group 3: Conference Agenda - Proposed agenda topics include analysis of global medical technology development trends and policy environments, research and transformation paths for imaging platforms, new consumables, brain-computer interfaces, interventional devices, and diagnostic equipment [5] - Other topics will cover experiences in the intersection of medicine and engineering, breakthroughs in AI-assisted diagnosis and digital therapy, and insights into technology directions and company profiles attracting domestic and foreign capital [5] Group 4: Participation and Submission Guidelines - The awards are open to medical device and digital medical technology companies with innovative products or platform technologies that demonstrate originality, advancement, and potential for large-scale industrialization [6] - Submission for the awards is open until May 31, 2025, with a review phase from June 1 to June 15, 2025, and results to be announced between June 16 and June 22, 2025 [10]

Core Viewpoint - The deadline for the 2025 Global Aesthetic Technology Innovation Awards has been extended to May 26, 2025, to allow more time for participants to prepare their submissions and showcase their innovations in the medical aesthetics field [1][2]. Group 1: Event Details - The event will take place on June 12, 2025, at the Beijing Zhongguancun Exhibition Center, with an expected attendance of 500 participants from various sectors including government, hospitals, and investment institutions [1]. - The conference will gather clinical experts, top scientists, technology innovators, and regulatory bodies to discuss cutting-edge developments, commercialization paths, regulatory trends, and market opportunities in the medical aesthetics industry [1][3]. Group 2: Award Categories - The awards include the 2025 Global Aesthetic Technology Innovation Award, aimed at companies and manufacturers that have made significant technological innovations in medical aesthetics [5]. - The 2025 Global Aesthetic Clinical Excellence Award recognizes products or technologies that have achieved notable results in clinical applications, receiving positive feedback from both doctors and patients [6]. - The 2025 Global Aesthetic Industry Service Award honors companies and institutions providing exceptional services in areas such as technology innovation, clinical trials, and production [7]. - The 2025 Global Aesthetic Innovation & Translation Award is for individuals who have made outstanding contributions to innovation in medical aesthetics, promoting products or solutions with industrialization potential [8]. Group 3: Evaluation Process - The evaluation will be conducted through expert reviews and meetings [9]. - The submission phase is open until May 26, 2025, followed by a review and selection process from May 27 to June 2, 2025, with winners notified between June 3 and June 6, 2025 [12].

Core Viewpoint - The Global Cardiovascular Conference 2025 highlighted the latest advancements in cardiovascular technology innovation, emphasizing the importance of clinical-driven and industry collaboration for the growth of the cardiovascular device sector [1][10][71]. Group 1: Conference Overview - The conference was held on May 15, 2025, in Beijing, gathering over 600 professionals from clinical, research, industry, and investment sectors to discuss cardiovascular technology innovation and enterprise growth paths [1]. - The event featured the release of the "2025 Global Cardiovascular Innovation Annual White Paper," which presented the latest development patterns in the cardiovascular device market [10]. Group 2: Awards and Recognition - The conference awarded three major prizes: the "2025 Global Cardiovascular Technology Innovation Award," the "2025 Global Cardiovascular Clinical Application Award," and the "2025 Global Cardiovascular International Cooperation Award," recognizing outstanding contributions in technology breakthroughs and clinical applications [13][14]. - A total of 10 companies received the technology innovation award, while 7 companies were recognized for clinical applications, and 4 units received the international cooperation award [13][14]. Group 3: Policy and Support - The Haidian District government expressed strong support for cardiovascular medical technology as a strategic direction, aiming to promote the market reach of cardiovascular devices [5]. - Beijing's policy support will focus on enhancing "clinical-driven + industry collaboration" mechanisms to facilitate innovation and results transformation in the cardiovascular field [7]. Group 4: Clinical and Engineering Collaboration - Experts emphasized the need for deep collaboration between clinical practitioners and engineers to address clinical pain points and drive innovation in cardiovascular devices [17][23]. - The conference featured discussions on the evolution of coronary intervention techniques and the importance of integrating clinical needs into device development [20][23]. Group 5: Investment Insights - The cardiovascular device sector is entering a critical window where companies with original technologies and systematic compliance capabilities will be highly valued by capital and policy [50]. - Early-stage companies face challenges in selecting the right market segments, while mid-stage companies must navigate structural adjustments and new payment logic to survive [51]. Group 6: Market Education and Product Strategy - The importance of educating the market on new surgical techniques and fostering collaboration between clinicians and engineers was highlighted as essential for successful product adoption [69]. - Companies are encouraged to build a product matrix that supports long-term growth and resilience against market fluctuations [63]. Group 7: Future Outlook - The conference served as a starting point for further discussions on how to leverage original technologies and promote Chinese innovations on the global stage [71][72]. - The cardiovascular industry is poised for transformation, driven by policy changes and technological advancements, necessitating a focus on clinical value and collaborative innovation [71].

Core Insights - The article emphasizes the collaboration between doctors, CEOs, engineers, and investors to address challenges in medical device innovation [1] - It highlights the "Medical Device Innovation and Engineering Transformation Workshop" organized by Shanghai Jiao Tong University, which aims to merge medical needs with engineering solutions [1][3] Course Highlights - Participants will learn to integrate medical pain points with engineering technology to create innovative medical products [3] - The workshop will cover the complete path from concept to market for medical devices, utilizing the Biodesign innovation methodology [3][7] - Attendees will have the opportunity to network with professionals from various fields, including doctors, engineers, and investors [3][8] Training Information - The workshop is scheduled for June 21-22, 2025, at Shanghai Jiao Tong University, with a fee of 8999 yuan per person [3][12] - The program includes high-intensity practical training over two days, focusing on medical innovation and technology layout [4][8] Course Structure - Day one will focus on medical innovation, technology layout, and practical exercises to foster collaboration among participants [4][6] - Day two will address the industrialization of innovations and funding pathways, including insights into medical device financing and government support policies [8][12] Expert Faculty - The faculty includes leading experts from Shanghai Jiao Tong University with extensive experience in medical technology and investment [9][10] - Notable faculty members have backgrounds in medical chip research, nanobiomedicine, and investment in high-tech medical companies [9][10] Networking Opportunities - The workshop will facilitate deep exchanges among cross-disciplinary experts, enhancing collaboration between technology and market needs [8][11] - Participants will have the chance to showcase their projects and receive feedback from mentors, potentially leading to investment and collaboration opportunities [11][12]